| IBD | Inflammatory bowel disease |
| CRP | C-reactive protein |
| 4EPS | 4-ethyl phenyl sulfate |
| BBB | Blood–brain barrier |
| GABA | Gamma-aminobutyric acid |
| IL | Interleukin |
| HPA | Hypothalamic–pituitary–adrenal |
| DNA | Deoxyribonucleic acid |
| RNA | Ribonucleic acid |
| BDNF | Brain-derived neurotrophic factor |
| 5-HTP | 5-hydroxytryptamine |
| SDV | Subdiaphragmatic vagotomy |
| LPS | Lipopolysaccharides |
| MDD | Major depressive disorder |
| SSRIs | Selective serotonin reuptake inhibitors |
| FRL | Flinders resistant line |
| GI | Gastrointestinal |
| IBS | Irritable bowel syndrome |
| FA | Fatty acids |
| TCAs | Tricyclic antidepressants |
| SNRIs | Serotonin-norepinephrine reuptake inhibitors |
| BZDs | Benzodiazepines |
| MAOI | Monoamine oxidase inhibitors |
| FDA | Food and Drug Administration |
| FMT | Fecal microbiota transplantation |
| FOS | Fructo-oligosaccharides |
| GOS | Galacto-oligosaccharides |
| mRNA | Messenger ribonucleic acid |